[{"orgOrder":0,"company":"BravoVax","sponsor":"Shanghai BravoBio Co., Ltd. | Novotech","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"CHINA","productType":"Vaccine","year":"2023","type":"Inapplicable","leadProduct":"Human Papillomavirus Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase I","graph3":"BravoVax","amount2":0,"highestDevelopmentShortName":"Ph I","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Intramuscular Injection","sponsorNew":"BravoVax \/ Shanghai BravoBio Co., Ltd. | Novotech","highestDevelopmentStatusID":"6","companyTruncated":"BravoVax \/ Shanghai BravoBio Co., Ltd. | Novotech"},{"orgOrder":0,"company":"Xiamen Innovax Biotech","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"CHINA","productType":"Vaccine","year":"2024","type":"Inapplicable","leadProduct":"Human Papillomavirus Vaccine","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase IV","graph3":"Xiamen Innovax Biotech","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Xiamen Innovax Biotech \/ Inapplicable","highestDevelopmentStatusID":"11","companyTruncated":"Xiamen Innovax Biotech \/ Inapplicable"},{"orgOrder":0,"company":"International Agency for Research on Cancer","sponsor":"University of New Mexico | University of Stellenbosch | University of KwaZulu | Coptic Hope Center | Gabrail Cancer Center Research | Ministry of Health, Swaziland | Baylor College of Medicine Children's Foundation | Sefako Makgatho Health Sciences Univer","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"","productType":"Vaccine","year":"2021","type":"Inapplicable","leadProduct":"Human Papillomavirus Vaccine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"International Agency for Research on Cancer","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"International Agency for Research on Cancer \/ University of New Mexico | University of Stellenbosch | University of KwaZulu | Coptic Hope Center | Gabrail Cancer Center Research | Ministry of Health, Swaziland | Baylor College of Medicine Children's Foundation | Sefako Makgatho Health Sciences Univer","highestDevelopmentStatusID":"10","companyTruncated":"International Agency for Research on Cancer \/ University of New Mexico | University of Stellenbosch | University of KwaZulu | Coptic Hope Center | Gabrail Cancer Center Research | Ministry of Health, Swaziland | Baylor College of Medicine Children's Foundation | Sefako Makgatho Health Sciences Univer"},{"orgOrder":0,"company":"ISA Pharmaceuticals","sponsor":"Regeneron Pharmaceuticals","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"NETHERLANDS","productType":"Vaccine","year":"2020","type":"Inapplicable","leadProduct":"Human Papillomavirus Vaccine","moa":"Undisclosed","graph1":"Oncology","graph2":"Phase II","graph3":"ISA Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"ISA Pharmaceuticals \/ Regeneron Pharmaceuticals","highestDevelopmentStatusID":"8","companyTruncated":"ISA Pharmaceuticals \/ Regeneron Pharmaceuticals"}]

Find Clinical Drug Pipeline Developments & Deals for Human Papillomavirus Vaccine

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Pharmaconex
                          Not Confirmed
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          April 03, 2024

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase IV

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Pharmaconex
                          Not Confirmed
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          January 05, 2023

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase I

                          Sponsor : Shanghai BravoBio Co., Ltd. | Novotech

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          International Agency for Research on Cancer

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          International Agency for Research on Cancer

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Infections and Infectious Diseases

                          Study Phase : Phase III

                          Sponsor : University of New Mexico | University of Stellenbosch | University of KwaZulu | Coptic Hope Center | Gabrail Cancer Center Research | Ministry of Health, Swaziland | Baylor College of Medicine Children's Foundation | Sefako Makgatho Health Sciences Univer

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          December 29, 2021

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase III

                          Sponsor : University of New Mexico | University of Stellenbosch | University of KwaZulu | Coptic Hope Center | Gabrail Cancer Center Research | Ministry of Health, Swaziland | Baylor College of Medicine Children's Foundation | Sefako Makgatho Health Sciences Univer

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Pharmaconex
                          Not Confirmed
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          May 21, 2020

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase II

                          Sponsor : Regeneron Pharmaceuticals

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          Shanghai Zerun Biotechnology Co.,Ltd

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Shanghai Zerun Biotechnology Co.,Ltd

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          April 03, 2019

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          Pharmaconex
                          Not Confirmed
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          September 13, 2018

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Oncology

                          Highest Development Status : Phase II

                          Sponsor : Regeneron Pharmaceuticals

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          Shanghai Bovax Biotechnology Co., Ltd.

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Shanghai Bovax Biotechnology Co., Ltd.

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          March 21, 2017

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Infections and Infectious Diseases

                          Highest Development Status : Phase I

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          Shanghai Zerun Biotechnology Co.,Ltd

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Shanghai Zerun Biotechnology Co.,Ltd

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          April 15, 2016

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Undisclosed

                          Highest Development Status : Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          University of Witwatersrand, South Africa

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          University of Witwatersrand, South Africa

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          August 23, 2013

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                          Highest Development Status : Phase II

                          Sponsor : Merck & Co

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          Xiamen University

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Xiamen University

                          Country arrow
                          Pharmaconex
                          Not Confirmed

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                          Study Phase : Phase III

                          Sponsor : Xiamen Innovax Biotech | Beijing Wantai Biological Pharmacy Enterprise | Ministry of Science and Technology, China

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Vaccine

                          Upfront Cash : Inapplicable

                          November 28, 2012

                          Lead Product(s) : Human Papillomavirus Vaccine

                          Therapeutic Area : Obstetrics/Gynecology (Women’s Health)

                          Highest Development Status : Phase III

                          Sponsor : Xiamen Innovax Biotech | Beijing Wantai Biological Pharmacy Enterprise | Ministry of Science and Technology, China

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank